CATHEDRA BITCOIN INC
CBTTF
Hive Blockchain
HIVE
Coinbase
COIN
Mawson Infrastructure
MIGI
SATO TECHNOLOGIES CORP
CCPUF
US Stock MarketDetailed Quotes
BPMC Blueprint Medicines
- 90.630
- -3.740-3.96%
Close Jan 8 16:00 ET
- 90.630
- 0.0000.00%
Post 16:44 ET
5.76BMarket Cap-43.36P/E (TTM)
94.880High90.155Low927.46KVolume93.870Open94.370Pre Close85.09MTurnover1.48%Turnover RatioLossP/E (Static)63.53MShares121.90052wk High18.39P/B5.70BFloat Cap72.24052wk Low--Dividend TTM62.86MShs Float125.610Historical High--Div YieldTTM5.01%Amplitude13.040Historical Low91.744Avg Price1Lot Size
Blueprint Medicines News
Stifel Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $155
Stifel Nicolaus Sticks to Its Buy Rating for Blueprint Medicines (BPMC)
J.P. Morgan Maintains Blueprint Medicines(BPMC.US) With Buy Rating
J.P. Morgan Sticks to Its Buy Rating for Blueprint Medicines (BPMC)
Blueprint Medicines Price Target Maintained With a $140.00/Share by Stephens & Co.
Blueprint Medicines Analyst Ratings
Barclays Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $105
JMP Securities Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $125
JMP Securities Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $125
TD Cowen Maintains Blueprint Medicines(BPMC.US) With Buy Rating
H.C. Wainwright Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $135
Needham Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $135
Morgan Stanley Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $120
Needham Reiterates Buy on Blueprint Medicines, Maintains $135 Price Target
Blueprint Medicines Analyst Ratings
J.P. Morgan Initiates Blueprint Medicines(BPMC.US) With Buy Rating, Announces Target Price $126
Blueprint Medicines Initiated With an Overweight at JPMorgan
Barclays Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $105
Mixed Efficacy and Safety Profiles Lead to Hold Rating for Blueprint Medicines and Cogent Biosciences
A Quick Look at Today's Ratings for Blueprint Medicines(BPMC.US), With a Forecast Between $105 to $135
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
